Dr. Macklis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
seidman LLs600
Cleveland, OH 44106Phone+1 216-844-2536Fax+1 216-286-3989
Summary
- Dr. Roger Macklis is a radiation oncologist in Cleveland, OH and is affiliated with multiple hospitals in the area, including University Hospitals Geauga Medical Center and University Hospitals Cleveland Medical Center. He received his medical degree from Harvard Medical School and has been in practice 33 years. He specializes in breast cancer and hematologic malignancies.
Education & Training
- Harvard Medical SchoolClass of 1983
- Yale UniversityB.S. and M.S., Molecular Biophysics, Summa Cum Laude, 1978
Certifications & Licensure
- OH State Medical License 1993 - 2026
- NY State Medical License 2001 - 2023
- CA State Medical License 2003 - 2021
- KY State Medical License 2017 - 2021
- MN State Medical License 2014 - 2020
- MI State Medical License 2001 - 2018
- MA State Medical License 1984 - 2012
- American Board of Radiology Radiation Oncology
- Join now to see all
Awards, Honors, & Recognition
- Who's Who in America 1998
- Who's Who in the World 1998
- Best Doctors in America 1998
- Join now to see all
Publications & Presentations
Journal Articles
- Radium-223 in the Treatment of Osteoblastic Metastases: A Criticial Clinical ReviewHumm JL. Sartor O. Parker C. Bruland O. and Macklis RM, Int.J Rad. Onc.Biol.Phys, 1/1/2015
- Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: Treatment outcomes in extranodal marginal zone subtypeCraig A. Portell, Mary E. Aronow, Lisa A. Rybicki, Roger Macklis, Arun D. Singh, John W. Sweetenham, Clinical Lymphoma Myeloma and Leukemia, 1/1/2013
- An Overview of 'Accountable Care Organizations' For Oncology SpecialistsAnish J Mehta1, Roger Macklis, J Onc Practice, 1/1/2013
- Join now to see all
Books/Book Chapters
Lectures
- Use of Radium-223 dichloride for the management of metastatic prostate cancer1/1/2014
- Alpha Particle Radiobiology for Radium-223 ("Alpharadin"): The Fortuitous "Goldilocks" Effect Observed For Hormone-Resistant Metastatic Prostate Cancer1/1/2012
- Alpha Particle Radiobiology for Radium-223 ("Alpharadin"): The Fortuitous "Goldilocks" Effect Observed For Hormone-Resistant Metastatic Prostate C...1/1/2012
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: